Press Release Source: Broadcom Corporation; BRCM Corporate
Commission Will Now Decide Appropriate Remedy for Qualcomm's Infringement
WASHINGTON, Dec. 11 /PRNewswire-FirstCall/ -- Broadcom Corporation (Nasdaq:
BRCM), a global leader in semiconductors for wired and wireless communications,
announced today that the U.S. International Trade Commission (ITC) has upheld an
initial determination that Qualcomm Incorporated (Nasdaq: QCOM) infringes five
claims of a Broadcom(R) patent.
The Commission will now consider the appropriate remedy for
Qualcomm's infringement, which could include a permanent exclusion order barring
the importation into the United States of infringing Qualcomm chips, a cease
and desist order barring Qualcomm from further use or sale of infringing
products in the United States, and/or an exclusion order barring the importation
into the United States of cellular phones containing infringing Qualcomm chips.
On October 10 ITC Administrative Law Judge Charles E. Bullock determined that
all three patents asserted in the ITC proceeding by Broadcom were valid, and
that one, U.S. Patent No. 6,714,983, was infringed by Qualcomm. The Commission's
decision, issued December 8, rejected Qualcomm's challenges to those findings.
The infringing products include cellular baseband processor chips that comprise
Qualcomm's core suite of enhanced multimedia and convergence handset platforms.
"Qualcomm expects other companies to respect and pay dearly for the use of its
intellectual property, but refuses to respect the intellectual property
of others. The Commission's decision is an important step toward leveling
that lopsided view," said David A. Dull, Broadcom's Senior Vice President
and General Counsel. "We fully intend to prosecute this ITC case to
conclusion, and to continue to aggressively enforce our patent rights against
Qualcomm in other pending cases."
In the next step of the ITC process, the Commission will receive additional
briefing from the parties regarding the appropriate remedy for Qualcomm's
infringement, and will issue its determination on remedy by February 9, 2007.
The President then has sixty days to approve or disapprove the remedy.
A recent IEEE Spectrum magazine survey ranked Broadcom at No. 5 among hundreds
of companies worldwide rated for the power of their patent portfolios. |
